±¤¿ªÇпä¹ý(PDT) ½ÃÀå : ¼¼°è »ê¾÷ ºÐ¼®, ±Ô¸ð, Á¡À¯À², ¼ºÀå, µ¿Çâ, ¿¹Ãø(2024-2031³â)
Photodynamic Therapy Market: Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2024 - 2031
»ùÇà ¿äû ¸ñ·Ï¿¡ Ãß°¡
Persistence Market Research´Â À̹ø¿¡ ¼¼°èÀÇ ±¤¿ªÇпä¹ý(PDT) ½ÃÀå¿¡ °üÇÑ Á¾ÇÕ º¸°í¼¸¦ ¹ßÇ¥Çß½À´Ï´Ù. ½ÃÀå ¼ºÀå ÃËÁø¿äÀΡ¤µ¿Ç⡤±âȸ¡¤°úÁ¦ µî, º»ÁúÀûÀÎ ½ÃÀå ¿ªÇÐÀ» »ó¼¼È÷ Æò°¡Çϰí, ½ÃÀå ±¸Á¶¿¡ °üÇÑ »ó¼¼ ÀλçÀÌÆ®¸¦ Á¦°øÇϰí ÀÖ½À´Ï´Ù.
ÁÖ¿ä ÀλçÀÌÆ®
±¤¿ªÇпä¹ý ½ÃÀå ±Ô¸ð(2024³â) : 35¾ï ´Þ·¯
¿¹Ãø ½ÃÀå ±Ô¸ð(2031³â) : 74¾ï ´Þ·¯
¼¼°è ½ÃÀå ¼ºÀå·ü(CAGR 2024-2031) : 7.1%
±¤¿ªÇпä¹ý ½ÃÀå - ¸®Æ÷Æ® ¹üÀ§ :
±¤ ¿ªÇÐ Ä¡·á´Â ƯÁ¤ ¾Ï, ³ëÈ È²¹Ýº¯¼º(AMD), Àü¾Ï º´º¯À» Æ÷ÇÔÇÑ ´Ù¾çÇÑ º´¸® Ä¡·á¿¡ Áß¿äÇÑ ¿ªÇÒÀ»Çϸç, PDT´Â ºû¿¡ ¹Î°¨ÇÑ ¾à¹°°ú ƯÁ¤ ÆÄÀåÀÇ ºûÀ» »ç¿ëÇÏ¿© Ç¥Àû ¼¼Æ÷¸¦ ÆÄ±«ÇÏ´Â µ¥ »ç¿ëµË´Ï´Ù. ±¤¿ªÇпä¹ý ½ÃÀåÀº º´¿ø, Á¾¾ç¼¾ÅÍ, ¾È°ú Ŭ¸®´Ð¿¡ ¼ºñ½º¸¦ Á¦°øÇϰí ÀÖÀ¸¸ç, °¨±¤Á¦, ±¤¿ø, Àü´Þ ½Ã½ºÅÛ µî ´Ù¾çÇÑ Ä¡·á Á¦Ç° ¹× ±â¼úÀ» Á¦°øÇÕ´Ï´Ù. ½ÃÀå ¼ºÀåÀÇ ¿øµ¿·ÂÀº ¾Ï ¹× ¸¸¼ºÁúȯÀÇ ¹ßº´·ü Áõ°¡, ÀÇ·á ÅõÀÚ Áõ°¡, Ä¡·á È¿°ú¿Í ȯÀÚ °á°ú¸¦ °³¼±ÇÏ´Â PDT ±â¼úÀÇ ¹ßÀüÀÔ´Ï´Ù.
½ÃÀå ¼ºÀåÀÇ ÃËÁø¿äÀÎ:
¼¼°è ±¤¿ªÇпä¹ý ½ÃÀåÀº È¿°úÀûÀÎ Ä¡·á ¿É¼ÇÀ» ÇÊ¿ä·Î ÇÏ´Â ¾Ï ¹× ±âŸ ¸¸¼ºÁúȯÀÇ À¯º´·ü Áõ°¡¿Í °°Àº ¸î °¡Áö ÁÖ¿ä ¿äÀο¡ ÀÇÇØ ÁÖµµµÇ°í ÀÖ½À´Ï´Ù. ºñħ½ÀÀûÀ̰í Ç¥ÀûÈµÈ ºñħ½ÀÀû Ä¡·á¿¡ ´ëÇÑ ¼ö¿ä Áõ°¡¿Í ±¤°¨ÀÛÁ¦ ÈÇÕ¹° ¹× ±¤Àü´Þ ½Ã½ºÅÛÀÇ ¹ßÀüÀº ½ÃÀå È®´ë¸¦ ÃËÁøÇϰí ÀÖÀ¸¸ç, AMD Ä¡·á¸¦ À§ÇØ ¾È°ú¿¡¼ PDT°¡ äÅõǰí ÀÖ°í, È¿´ÉÀ» °³¼±ÇÏ°í ºÎÀÛ¿ëÀ» ÁÙÀÎ »õ·Î¿î PDT ¾à¹°ÀÇ °³¹ßµµ ½ÃÀå È®´ë¿¡ ±â¿©Çϰí ÀÖ½À´Ï´Ù. ¶ÇÇÑ ÀÇ·á ÀÎÇÁ¶óÀÇ È®´ë¿Í PDT ¿¬±¸ Ȱµ¿ÀÇ È°¼ºÈ´Â ½ÃÀå ÁøÃâ±â¾÷¿¡°Ô »õ·Î¿î ±âȸ¸¦ Á¦°øÇÕ´Ï´Ù.
½ÃÀå ¼ºÀå ¾ïÁ¦¿äÀÎ :
Àü¸ÁÀÌ ¹àÀº ±¤¿ªÇпä¹ý ½ÃÀåÀº ³ôÀº Ä¡·á ºñ¿ë, Á¦ÇÑµÈ »óȯ ¹üÀ§, ÀáÀçÀû ºÎÀÛ¿ë µîÀÇ ¹®Á¦¿¡ Á÷¸éÇØ ÀÖÀ¸¸ç, ƯÈ÷ ÀÇ·á ¿¹»êÀÌ Á¦ÇÑµÈ ½ÅÈï ½ÃÀå¿¡¼´Â PDT Àåºñ¿Í ±¤°¨ÀÛÁ¦ÀÇ ºñ¿ëÀÌ ÀϺΠÀÇ·á ½Ã½ºÅÛ°ú ȯÀÚ¿¡°Ô´Â ºÎ´ã½º·¯¿ï ¼ö ÀÖ½À´Ï´Ù. ¶ÇÇÑ PDT Ä¡·á¿¡ ´ëÇÑ Á¦ÇÑÀûÀÎ º¸Çè±Þ¿©¿Í ÇǺΠ°ú¹Î¼º ¹× ¼Õ»ó°ú °°Àº ÀáÀçÀû ºÎÀÛ¿ë¿¡ ´ëÇÑ ¿ì·Á´Â ½ÃÀå ħÅõ¸¦ °¡·Î¸·´Â Àå¾Ö¹°ÀÌ µÇ°í ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ À庮À» ±Øº¹Çϱâ À§Çؼ´Â ¾÷°è ÀÌÇØ°ü°èÀÚ, ÀÇ·á ÇÁ·Î¹ÙÀÌ´õ ¹× Á¤Ã¥ ÀÔ¾ÈÀÚµéÀÌ Çù·ÂÇÏ¿© PDT ¼Ö·ç¼Ç¿¡ ´ëÇÑ Á¢±Ù¼º°ú °æÁ¦¼ºÀ» °³¼±ÇÒ Çʿ䰡 ÀÖ½À´Ï´Ù.
½ÃÀå ±âȸ :
±¤ ¿ªÇÐ Ä¡·á ½ÃÀåÀº ±â¼ú Çõ½Å, Àα¸ µ¿Çâ, Ä¡·á ÆÐ·¯´ÙÀÓÀÇ ÁøÈ·Î ÀÎÇØ Å« ¼ºÀå ±âȸ¸¦ ¸ÂÀÌÇϰí ÀÖ½À´Ï´Ù. ƯÀ̼ºÀÌ °ÈµÇ°í Àü½Å µ¶¼ºÀÌ °¨¼ÒµÈ ÷´Ü ±¤°¨ÀÛÁ¦ÀÇ °³¹ßÀº »õ·Î¿î Ä¡·á °¡´É¼ºÀ» Á¦°øÇÕ´Ï´Ù. ¶ÇÇÑ PDT¿Í ÈÇпä¹ý, ¸é¿ª¿ä¹ý µî ´Ù¸¥ Ä¡·á¹ý°úÀÇ ÅëÇÕÀ¸·Î ±× Àû¿ë ¹üÀ§°¡ È®´ëµÇ°í ÀÖ½À´Ï´Ù. ¸ÂÃãÇü ÀÇ·áÀÇ ºÎ»ó°ú Áúº´ÀÇ Á¶±â ¹ß°ß ¹× Á¶±â Ä¡·á¿¡ ´ëÇÑ °ü½ÉÀÌ ³ô¾ÆÁü¿¡ µû¶ó PDT´Â »õ·Î¿î ±æÀ» ¿¾î°¡°í ÀÖ½À´Ï´Ù. R&D¿¡ ´ëÇÑ Àü·«Àû ÅõÀÚ, Àü·«Àû Á¦ÈÞ, ºñ¿ë È¿À²ÀûÀÎ PDT ¼Ö·ç¼ÇÀÇ µµÀÔÀº »õ·Î¿î ±âȸ¸¦ Ȱ¿ëÇÏ°í ½ÃÀå ¸®´õ½ÊÀ» À¯ÁöÇÏ´Â µ¥ ¸Å¿ì Áß¿äÇÕ´Ï´Ù.
ÀÌ º¸°í¼¿¡¼ ´Ù·é ÁÖ¿ä Áú¹®
¼¼°è ±¤¿ªÇпä¹ý ½ÃÀåÀÇ ¼ºÀåÀ» °¡¼ÓÇÏ´Â ÁÖ¿ä ¿äÀÎÀº ¹«¾ùÀΰ¡?
´Ù¾çÇÑ ÀÇ·á ºÐ¾ß¿¡¼ äÅÃÀ» ÁÖµµÇϰí ÀÖ´Â PDT ¿ëµµ¿Í ±â¼úÀº ¹«¾ùÀΰ¡?
±â¼ú ¹ßÀü°ú Çõ½ÅÀº PDT ½ÃÀå °æÀï ±¸µµ¸¦ ¾î¶»°Ô º¯È½Ã۰í Àִ°¡?
±¤ ¿ªÇÐ Ä¡·á ½ÃÀå¿¡ ±â¿©ÇÏ´Â ÁÖ¿ä ±â¾÷Àº ¾îµðÀ̸ç, ½ÃÀå¿¡¼ÀÇ ÀÔÁö¸¦ À¯ÁöÇϱâ À§ÇØ ¾î¶² Àü·«À» äÅÃÇϰí Àִ°¡?
¼¼°è ±¤¿ªÇпä¹ý ½ÃÀåÀÇ »õ·Î¿î µ¿Çâ¿Í ¹Ì·¡ Àü¸ÁÀº?
¸ñÂ÷
Á¦1Àå °³¿ä
Á¦2Àå ½ÃÀå °³¿ä
½ÃÀå ¹üÀ§/ ºÐ·ù
½ÃÀåÀÇ Á¤ÀÇ/ ¹üÀ§/ Á¦ÇÑ
Á¦3Àå ÁÖ¿ä ½ÃÀå µ¿Çâ
Áúº´ ¿ªÇÐ(2019)
ȯÀÚ Ä¡·áÀÇ °úÁ¤
±¤¼± ¿ä¹ý Ä¡·á ÆÐÅÏ
¹Ì¿ë Ä¡·áÀÇ ½Ã¼ú °Ç¼ö
Á¦4Àå ÁÖ¿ä ¼º°ø ¿äÀÎ
ÃÖ±Ù Á¦Ç° ¸±¸®½º
±ÔÁ¦ ½Ã³ª¸®¿À
±¤¼±°¢ÈÁõ ¹× ±âÀú¼¼Æ÷¾ÏÀÇ Áúº´ ¿ªÇÐ(2019)
Á¦Á¶¾÷ü¿¡ ÀÇÇÑ Àü·«Àû ÇÁ·Î¸ð¼Ç Àü·«
Á¦5Àå ¼¼°èÀÇ ±¤¼± ¿ªÇÐ ¿ä¹ý ½ÃÀå - °¡°Ý ºÐ¼®
Á¦Ç° À¯Çüº° Áö¿ªº° °¡°Ý ºÐ¼®
¼¼°è Æò±Õ °¡°Ý ºÐ¼® º¥Ä¡¸¶Å©
Á¦6Àå ¼¼°èÀÇ ±¤¼± ¿ªÇÐ ¿ä¹ý ½ÃÀåÀÇ ¼ö¿ä
°ú°Å ½ÃÀå ±Ý¾×(10¾ï ´Þ·¯) ºÐ¼®, 2019-2023³â
ÇöÀç ¹× ÇâÈÄ ½ÃÀå ±Ý¾×(10¾ï ´Þ·¯) ¿¹Ãø, 2024-2031³â
Àü³â´ëºñ ¼ºÀå µ¿Ç⠺м®
Àý´ëÀû ¸ÅÃâ ±âȸ
Á¦7Àå ½ÃÀå ¹è°æ
°Å½Ã°æÁ¦ ¿äÀÎ
¿¹Ãø ¿äÀÎ - °ü·Ã¼º°ú ¿µÇâ
½ÃÀå ¿ªÇÐ
Á¦8Àå ¼¼°èÀÇ ±¤¼± ¿ªÇÐ ¿ä¹ý ½ÃÀå ºÐ¼® : Á¦Ç° À¯Çüº°
¼·Ð/ÁÖ¿ä Á¶»ç °á°ú
°ú°Å ½ÃÀå ±Ô¸ð(10¾ï ´Þ·¯) ºÐ¼®, Á¦Ç° À¯Çüº°, 2019-2023³â
ÇöÀç ¹× ÇâÈÄ ½ÃÀå ±Ô¸ð(10¾ï ´Þ·¯) ºÐ¼®°ú ¿¹Ãø, Á¦Ç° À¯Çüº°, 2024-2031³â
±¤°¨¼ö¼º¾à
Hematoporphyrin derivative(HpD)
Aminolevulinic acid(ALA)
Benzoporphyrin derivative(BPD)
Texaphyrins
Chlorins
¿°·á
±â±â
ÀÏȸ¿ë ±¤¼¶À¯ ±¤Àü¼Û ±â±â
´ÙÀÌ¿Àµå ·¹ÀÌÀú
½ÃÀåÀÇ ¸Å·Â ºÐ¼® : Á¦Ç° À¯Çüº°
Á¦9Àå ¼¼°èÀÇ ±¤¼± ¿ªÇÐ ¿ä¹ý ½ÃÀå ºÐ¼® : ¿ëµµº°
¼·Ð/ÁÖ¿ä Á¶»ç °á°ú
°ú°Å ½ÃÀå ±Ô¸ð(10¾ï ´Þ·¯) ºÐ¼®, ¿ëµµº°, 2019-2023³â
ÇöÀç ¹× ÇâÈÄ ½ÃÀå ±Ô¸ð(10¾ï ´Þ·¯) ºÐ¼®°ú ¿¹Ãø, ¿ëµµº°, 2024-2031³â
±âÀú¼¼Æ÷¾Ï
±¤¼±°¢ÈÁõ
±âŸ
°Ç¼±
¿©µå¸§
ÁÖ»ç(Rosacea)
ºñ¼Ò¼¼Æ÷ Æó¾Ï
½Äµµ¾Ï
¾È°ú
½ÃÀåÀÇ ¸Å·Â ºÐ¼® : ¿ëµµº°
Á¦10Àå ¼¼°èÀÇ ±¤¼± ¿ªÇÐ ¿ä¹ý ½ÃÀå ºÐ¼® : ÃÖÁ¾»ç¿ëÀÚº°
¼·Ð/ÁÖ¿ä Á¶»ç °á°ú
°ú°Å ½ÃÀå ±Ô¸ð(10¾ï ´Þ·¯) ºÐ¼®, ÃÖÁ¾»ç¿ëÀÚº°, 2019-2023³â
ÇöÀç ¹× ÇâÈÄ ½ÃÀå ±Ô¸ð(10¾ï ´Þ·¯) ºÐ¼®°ú ¿¹Ãø, ÃÖÁ¾»ç¿ëÀÚº°, 2024-2031³â
º´¿ø
¹Î°£ ÇǺΰú Ŭ¸®´Ð
·¹ÀÌÀú Ä¡·á ¼¾ÅÍ
¾ÏÄ¡·á ¼¾ÅÍ
½ºÆÄ¿Í ȸÃá ¼¾ÅÍ
½ÃÀåÀÇ ¸Å·Â ºÐ¼® : ÃÖÁ¾»ç¿ëÀÚº°
Á¦11Àå ºÏ¹ÌÀÇ ±¤¼± ¿ªÇÐ ¿ä¹ý ½ÃÀå ºÐ¼®
Á¦12Àå ¶óÆ¾¾Æ¸Þ¸®Ä«ÀÇ ±¤¼± ¿ªÇÐ ¿ä¹ý ½ÃÀå ºÐ¼®
Á¦13Àå À¯·´ÀÇ ±¤¼± ¿ªÇÐ ¿ä¹ý ½ÃÀå ºÐ¼®
Á¦14Àå ³²¾Æ½Ã¾ÆÀÇ ±¤¼± ¿ªÇÐ ¿ä¹ý ½ÃÀå ºÐ¼®
Á¦15Àå µ¿¾Æ½Ã¾ÆÀÇ ±¤¼± ¿ªÇÐ ¿ä¹ý ½ÃÀå ºÐ¼®
Á¦16Àå ¿À¼¼¾Æ´Ï¾Æ ±¤¼± ¿ªÇÐ ¿ä¹ý ½ÃÀå ºÐ¼®
Á¦17Àå Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«ÀÇ ±¤¼± ¿ªÇÐ ¿ä¹ý ½ÃÀå ºÐ¼®
Á¦18Àå ½ÅÈï ±¹°¡ ±¤¼± ¿ªÇÐ ¿ä¹ý ½ÃÀå ºÐ¼®
¼·Ð
ÁÖ¿ä ±¹°¡º° ½ÃÀå ±Ý¾× ºñÀ² ºÐ¼®
¼¼°è¿Í ±¹°¡º°ÀÇ ¼ºÀå ºñ±³
Áß±¹ ±¤¼± ¿ªÇÐ ¿ä¹ý ½ÃÀå ºÐ¼®
¼·Ð
½ÃÀå ºÐ·ù¿¡ ÀÇÇÑ ½ÃÀå ±Ý¾× ºñÀ² ºÐ¼®
½ÃÀå ºÐ·ùº° ½ÃÀå ±Ý¾×(10¾ï ´Þ·¯) ºÐ¼®°ú ¿¹Ãø
Á¦Ç° À¯Çü
ÃÖÁ¾»ç¿ëÀÚº°
¿ëµµº°
Çѱ¹ÀÇ ±¤¼± ¿ªÇÐ ¿ä¹ý ½ÃÀå ºÐ¼®
¼·Ð
½ÃÀå ºÐ·ù¿¡ ÀÇÇÑ ½ÃÀå ±Ý¾× ºñÀ² ºÐ¼®
½ÃÀå ºÐ·ùº° ½ÃÀå ±Ý¾×(10¾ï ´Þ·¯) ºÐ¼®°ú ¿¹Ãø
Á¦Ç° À¯Çü
ÃÖÁ¾»ç¿ëÀÚº°
¿ëµµº°
·¯½Ã¾Æ ±¤¼± ¿ªÇÐ ¿ä¹ý ½ÃÀå ºÐ¼®
¼·Ð
°¡°Ý ºÐ¼®
PEST ºÐ¼®
½ÃÀå ºÐ·ù¿¡ ÀÇÇÑ ½ÃÀå ±Ý¾× ºñÀ² ºÐ¼®
½ÃÀå ºÐ·ùº° ½ÃÀå ±Ý¾×(10¾ï ´Þ·¯) ºÐ¼®°ú ¿¹Ãø
Á¦Ç° À¯Çü
ÃÖÁ¾»ç¿ëÀÚº°
¿ëµµº°
Çѱ¹ÀÇ ±¤¼± ¿ªÇÐ ¿ä¹ý ½ÃÀå - °æÀï ±¸µµ
Á¦19Àå °æÀï ºÐ¼®
°æÀï ´ë½Ãº¸µå
°æÀï º¥Ä¡¸¶Å·
°æÀï µö ´ÙÀ̺ê(±¤°¨¼ö¼º¾à Á¦Á¶¾÷ü)
Galderma SA
Sun Pharmaceutical Industries Ltd.
Biofrontera
Novartis AG
Allergan Plc
°æÀï µö ´ÙÀ̺ê(PDT µð¹ÙÀ̽º Á¦Á¶¾÷ü)
Valeant Pharmaceuticals International, Inc
°³¿ä
Á¦Ç° Æ÷Æ®Æú¸®¿À
½ÃÀå ºÎ¹®º° ¼öÀͼº(Á¦Ç°/ä³Î/Áö¿ª)
ÆÇ¸Å °ÅÁ¡
Àü·« °³¿ä
¸¶ÄÉÆÃ Àü·«
Á¦Ç° Àü·«
ä³Î Àü·«
Quest Pharmatech, Inc.
°³¿ä
Á¦Ç° Æ÷Æ®Æú¸®¿À
½ÃÀå ºÎ¹®º° ¼öÀͼº(Á¦Ç°/ä³Î/Áö¿ª)
ÆÇ¸Å °ÅÁ¡
Àü·« °³¿ä
¸¶ÄÉÆÃ Àü·«
Á¦Ç° Àü·«
ä³Î Àü·«
Hologic, Inc.(Cynosure Inc.)
°³¿ä
Á¦Ç° Æ÷Æ®Æú¸®¿À
½ÃÀå ºÎ¹®º° ¼öÀͼº(Á¦Ç°/ä³Î/Áö¿ª)
ÆÇ¸Å °ÅÁ¡
Àü·« °³¿ä
¸¶ÄÉÆÃ Àü·«
Á¦Ç° Àü·«
ä³Î Àü·«
Á¦20Àå »ç¿ëµÇ´Â °¡Á¤°ú µÎÀÚ¾î
Á¦21Àå Á¶»ç ¹æ¹ý
KSA
Persistence Market Research has recently released a comprehensive report on the worldwide market for photodynamic therapy (PDT). This report provides an in-depth assessment of essential market dynamics, including drivers, trends, opportunities, and challenges, offering detailed insights into the market structure.
Key Insights:
Photodynamic Therapy Market Size (2024): USD 3.5 Bn
Projected Market Value (2031): USD 7.4 Bn
Global Market Growth Rate (CAGR 2024- 2031): 7.1%
Photodynamic Therapy Market - Report Scope:
Photodynamic therapy plays a crucial role in the treatment of various medical conditions, including certain cancers, age-related macular degeneration (AMD), and precancerous lesions. PDT utilizes light-sensitive drugs and specific wavelengths of light to destroy targeted cells. The photodynamic therapy market serves hospitals, oncology centers, and ophthalmology clinics, offering various therapeutic products and technologies, including photosensitizers, light sources, and delivery systems. Market growth is driven by increasing incidence of cancer and chronic diseases, rising healthcare investments, and advancements in PDT technology, which improve treatment effectiveness and patient outcomes.
Market Growth Drivers:
The global photodynamic therapy market is driven by several key factors, including the growing prevalence of cancer and other chronic conditions requiring effective treatment options. The rising demand for non-invasive and targeted therapies, along with advancements in photosensitizer compounds and light delivery systems, is fostering market expansion. The increasing adoption of PDT in ophthalmology for AMD treatment and the development of novel PDT agents with improved efficacy and reduced side effects are also contributing to market growth. Additionally, expanding healthcare infrastructure and increased research activities in PDT are creating new opportunities for market players.
Market Restraints:
Despite promising growth prospects, the photodynamic therapy market faces challenges related to high treatment costs, limited reimbursement coverage, and potential side effects. The cost of PDT equipment and photosensitizers can be prohibitive for some healthcare systems and patients, particularly in emerging markets with constrained healthcare budgets. Additionally, the limited availability of reimbursement for PDT procedures and concerns about potential adverse effects, such as skin sensitivity and damage, pose challenges for market penetration. Addressing these barriers requires collaboration between industry stakeholders, healthcare providers, and policymakers to improve access and affordability of PDT solutions.
Market Opportunities:
The photodynamic therapy market presents significant growth opportunities driven by technological innovations, demographic trends, and evolving treatment paradigms. The development of advanced photosensitizers with enhanced specificity and reduced systemic toxicity offers new therapeutic possibilities. Moreover, the integration of PDT with other treatment modalities, such as chemotherapy and immunotherapy, is expanding its application scope. The rise of personalized medicine and the increasing focus on early disease detection and treatment are creating new avenues for PDT. Strategic investments in R&D, strategic partnerships, and the introduction of cost-effective PDT solutions are crucial for capitalizing on emerging opportunities and maintaining market leadership.
Key Questions Answered in the Report:
What are the primary factors driving the growth of the photodynamic therapy market globally?
Which PDT applications and technologies are leading the adoption across different medical fields?
How are technological advancements and innovations reshaping the competitive landscape of the PDT market?
Who are the key players contributing to the photodynamic therapy market, and what strategies are they employing to sustain their market presence?
What are the emerging trends and future prospects in the global photodynamic therapy market?
Competitive Intelligence and Business Strategy:
Leading players in the global photodynamic therapy market, including Pfizer Inc., Theralase Technologies Inc., and Galderma S.A., focus on innovation, product differentiation, and strategic partnerships to gain a competitive edge. These companies invest in R&D to develop advanced PDT products and technologies, including novel photosensitizers, next-generation light delivery systems, and combination therapies. Collaborations with research institutions, healthcare providers, and regulatory bodies facilitate market access and technology adoption. Emphasis on clinical trials, evidence-based practices, and patient education is also crucial for driving market growth and enhancing treatment outcomes in the evolving PDT landscape.
Key Companies Profiled:
Givaudan
International Flavors & Fragrances Inc
MANE
Firmenich SA
BASF SE
Avon Products, Inc.
Shiseido Company
Limited, Chanel S.A
Clarins Fragrance Group
COTY INC., LVMH, L'Oreal Group
VIORYL S.A.
Zanos Ltd.
Artiste
INDESSO AROMA
Aroma Chemical Services International Gmbh
Photodynamic Therapy Market Segmentation
By Product Type
Photosensitizer Drugs
Photodynamic Therapy Devices
By Application
By Region
North America
Europe
Latin America
Western Europe
Eastern Europe
South Asia and Pacific
East Asia
The Middle East and Africa
Table of Contents
1. Executive Summary
1.1. Global Market Outlook
1.2. Demand Side Trends
1.3. Supply Side Trends
1.4. Analysis and Recommendations
2. Market Overview
2.1. Market Coverage / Taxonomy
2.2. Market Definition / Scope / Limitations
3. Key Market Trends
3.1. Disease Epidemiology (2019)
3.2. Patient Treatment Journey
3.3. Phototherapy Treatment Patterns
3.4. Procedure Volume of Cosmetic Therapies
4. Key Success Factors
4.1. Recent Product Launches
4.2. Regulatory Scenario
4.3. Disease Epidemiology For Actinic Keratosis & Basal Cell Carcinoma (2019)
4.4. Strategic Promotional Strategies, By Manufacturers
5. Global Photodynamic Therapy Market - Pricing Analysis
5.1. Regional Pricing Analysis By Product Type
5.2. Global Average Pricing Analysis Benchmark
6. Global Photodynamic Therapy Market Demand (in Value or Size in US$ Bn ) Analysis 2019-2023 and Forecast, 2024 - 2031
6.1. Historical Market Value (US$ Bn ) Analysis, 2019-2023
6.2. Current and Future Market Value (US$ Bn ) Projections, 2024 - 2031
6.2.1. Y-o-Y Growth Trend Analysis
6.2.2. Absolute $ Opportunity Analysis
7. Market Background
7.1. Macro-Economic Factors
7.1.1. Global GDP Growth Outlook
7.1.2. Global Healthcare Industry Outlook
7.2. Forecast Factors - Relevance & Impact
7.2.1. Recent Product Launches
7.2.2. Prevalence of Skin Disorders and Cancer
7.2.3. Adoption of Photodynamic Therapy For Skin and Cancer Treatment
7.2.4. Top Companies Historical Growth
7.2.5. Per Capita Healthcare Expenditure In Different Economies
7.3. Market Dynamics
7.3.1. Drivers
7.3.2. Restraints
7.3.3. Opportunity Analysis
8. Global Photodynamic Therapy Market Analysis 2019-2023 and Forecast 2024 - 2031, by Product Type
8.1. Introduction / Key Findings
8.2. Historical Market Size (US$ Bn ) Analysis By Product Type, 2019-2023
8.3. Current and Future Market Size (US$ Bn ) Analysis and Forecast By Product Type, 2024 - 2031
8.3.1. Photosensitizer Drugs
8.3.1.1. Hematoporphyrin derivative (HpD)
8.3.1.2. Aminolevulinic acid (ALA)
8.3.1.3. Benzoporphyrin derivative (BPD)
8.3.1.4. Texaphyrins
8.3.1.5. Chlorins
8.3.1.6. Dyes
8.3.2. Devices
8.3.2.1. Disposable Fiberoptic Light Delivery Devices
8.3.2.2. Diode Laser
8.4. Market Attractiveness Analysis By Product Type
9. Global Photodynamic Therapy Market Analysis 2019-2023 and Forecast 2024 - 2031, by Application
9.1. Introduction / Key Findings
9.2. Historical Market Size (US$ Bn ) Analysis By Application, 2019-2023
9.3. Current and Future Market Size (US$ Bn ) Analysis and Forecast By Application, 2024 - 2031
9.3.1. Basal Cell Carcinoma
9.3.2. Actinic Keratosis
9.3.3. Others
9.3.3.1. Psoriasis
9.3.3.2. Acne
9.3.3.3. Rosacea
9.3.3.4. Non-Small Cell Lung Cancer
9.3.3.5. Esophageal Cancer
9.3.3.6. Ophthalmology
9.4. Market Attractiveness Analysis By Application
10. Global Photodynamic Therapy Market Analysis 2019-2023 and Forecast 2024 - 2031, by End User
10.1. Introduction / Key Findings
10.2. Historical Market Size (US$ Bn ) Analysis By End User, 2019-2023
10.3. Current and Future Market Size (US$ Bn ) Analysis and Forecast By End User, 2024 - 2031
10.3.1. Hospitals
10.3.2. Private Dermatology Clinics
10.3.3. Laser Therapy Centers
10.3.4. Cancer Treatment Centers
10.3.5. Spas and Rejuvenation Centers
10.4. Market Attractiveness Analysis By End User
11. North America Photodynamic Therapy Market Analysis 2019-2023 and Forecast 2024 - 2031
11.1. Introduction
11.2. Pricing Analysis
11.3. Historical Market Size (US$ Bn ) Trend Analysis By Market Taxonomy, 2019-2023
11.4. Market Size (US$ Bn ) Forecast By Market Taxonomy, 2024 - 2031
11.4.1. By Country
11.4.1.1. U.S.
11.4.1.2. Canada
11.4.2. By Product Type
11.4.3. By Application
11.4.4. By End User
11.5. Market Attractiveness Analysis
11.5.1. By Country
11.5.2. By Product Type
11.5.3. By Application
11.5.4. By End User
11.6. Market Trends
12. Latin America Photodynamic Therapy Market Analysis 2019-2023 and Forecast 2024 - 2031
12.1. Introduction
12.2. Pricing Analysis
12.3. Historical Market Size (US$ Bn ) Trend Analysis By Market Taxonomy, 2019-2023
12.4. Market Size (US$ Bn ) Forecast By Market Taxonomy, 2024 - 2031
12.4.1. By Country
12.4.1.1. Brazil
12.4.1.2. Mexico
12.4.1.3. Rest of Latin America
12.4.2. By Product Type
12.4.3. By Application
12.4.4. By End User
12.5. Market Attractiveness Analysis
12.5.1. By Country
12.5.2. By Product Type
12.5.3. By Application
12.5.4. By End User
12.6. Market Trends
13. Europe Photodynamic Therapy Market Analysis 2019-2023 and Forecast 2024 - 2031
13.1. Introduction
13.2. Pricing Analysis
13.3. Historical Market Size (US$ Bn ) Trend Analysis By Market Taxonomy, 2019-2023
13.4. Market Size (US$ Bn ) Forecast By Market Taxonomy, 2024 - 2031
13.4.1. By Country
13.4.1.1. Germany
13.4.1.2. Italy
13.4.1.3. France
13.4.1.4. U.K.
13.4.1.5. Spain
13.4.1.6. Russia
13.4.1.7. Poland
13.4.1.8. Rest of Europe
13.4.2. By Product Type
13.4.3. By Application
13.4.4. By End User
13.5. Market Attractiveness Analysis
13.5.1. By Country
13.5.2. By Product Type
13.5.3. By Application
13.5.4. By End User
13.6. Market Trends
14. South Asia Photodynamic Therapy Market Analysis 2019-2023 and Forecast 2024 - 2031
14.1. Introduction
14.2. Pricing Analysis
14.3. Historical Market Size (US$ Bn ) Trend Analysis By Market Taxonomy, 2019-2023
14.4. Market Size (US$ Bn ) Forecast By Market Taxonomy, 2024 - 2031
14.4.1. By Country
14.4.1.1. India
14.4.1.2. Thailand
14.4.1.3. Indonesia
14.4.1.4. Malaysia
14.4.1.5. Rest of South Asia
14.4.2. By Product Type
14.4.3. By Application
14.4.4. By End User
14.5. Market Attractiveness Analysis
14.5.1. By Country
14.5.2. By Product Type
14.5.3. By Application
14.5.4. By End User
14.6. Market Trends
15. East Asia Photodynamic Therapy Market Analysis 2019-2023 and Forecast 2024 - 2031
15.1. Introduction
15.2. Pricing Analysis
15.3. Historical Market Size (US$ Bn ) Trend Analysis By Market Taxonomy, 2019-2023
15.4. Market Size (US$ Bn ) Forecast By Market Taxonomy, 2024 - 2031
15.4.1. By Country
15.4.1.1. China
15.4.1.2. Japan
15.4.1.3. South Korea
15.4.2. By Product Type
15.4.3. By Application
15.4.4. By End User
15.5. Market Attractiveness Analysis
15.5.1. By Country
15.5.2. By Product Type
15.5.3. By Application
15.5.4. By End User
15.6. Market Trends
16. Oceania Photodynamic Therapy Market Analysis 2019-2023 and Forecast 2024 - 2031
16.1. Introduction
16.2. Pricing Analysis
16.3. Historical Market Size (US$ Bn ) Trend Analysis By Market Taxonomy, 2019-2023
16.4. Market Size (US$ Bn ) Forecast By Market Taxonomy, 2024 - 2031
16.4.1. By Country
16.4.1.1. Australia
16.4.1.2. New Zealand
16.4.2. By Product Type
16.4.3. By Application
16.4.4. By End User
16.5. Market Attractiveness Analysis
16.5.1. By Country
16.5.2. By Product Type
16.5.3. By Application
16.5.4. By End User
16.6. Market Trends
17. Middle East and Africa Photodynamic Therapy Market Analysis 2019-2023 and Forecast 2024 - 2031
17.1. Introduction
17.2. Pricing Analysis
17.3. Historical Market Size (US$ Bn ) Trend Analysis By Market Taxonomy, 2019-2023
17.4. Market Size (US$ Bn ) Forecast By Market Taxonomy, 2024 - 2031
17.4.1. By Country
17.4.1.1. GCC Countries
17.4.1.2. South Africa
17.4.1.3. Rest of Middle East and Africa
17.4.2. By Product Type
17.4.3. By Application
17.4.4. By End User
17.5. Market Attractiveness Analysis
17.5.1. By Country
17.5.2. By Product Type
17.5.3. By Application
17.5.4. By End User
17.6. Market Trends
17.7. Key Market Participants - Intensity Mapping
17.8. Drivers and Restraints - Impact Analysis
18. Emerging Countries Photodynamic Therapy Market Analysis 2019-2023 and Forecast 2024 - 2031
18.1. Introduction
18.1.1. Market Value Proportion Analysis, By Key Countries
18.1.2. Global Vs. Country Growth Comparison
18.2. China Photodynamic Therapy Market Analysis
18.2.1. Introduction
18.2.2. Market Value Proportion Analysis by Market Taxonomy
18.2.3. Market Value (US$ Bn ) Analysis and Forecast by Market Taxonomy
18.2.3.1. By Product Type
18.2.3.2. By End User
18.2.3.3. By Application
18.3. South Korea Photodynamic Therapy Market Analysis
18.3.1. Introduction
18.3.2. Market Value Proportion Analysis by Market Taxonomy
18.3.3. Market Value (US$ Bn ) Analysis and Forecast by Market Taxonomy
18.3.3.1. By Product Type
18.3.3.2. By End User
18.3.3.3. By Application
18.4. Russia Photodynamic Therapy Market Analysis
18.4.1. Introduction
18.4.2. Pricing Analysis
18.4.3. PEST Analysis
18.4.4. Market Value Proportion Analysis by Market Taxonomy
18.4.5. Market Value (US$ Bn ) Analysis and Forecast by Market Taxonomy
18.4.5.1. By Product Type
18.4.5.2. By End User
18.4.5.3. By Application
18.4.6. South Korea Photodynamic Therapy Market - Competition Landscape
19. Competition Analysis
19.1. Competition Dashboard
19.2. Competition Benchmarking
19.3. Competition Deep Dive (Photosensitizer Drug Manufactures)
19.3.1. Galderma S.A.
19.3.1.1. Overview
19.3.1.2. Product Portfolio
19.3.1.3. Profitability by Market Segments (Product/Channel/Region)
19.3.1.4. Sales Footprint
19.3.1.5. Strategy Overview
19.3.1.5.1. Marketing Strategy
19.3.1.5.2. Product Strategy
19.3.1.5.3. Channel Strategy
19.3.2. Sun Pharmaceutical Industries Ltd.
19.3.2.1. Overview
19.3.2.2. Product Portfolio
19.3.2.3. Profitability by Market Segments (Product/Channel/Region)
19.3.2.4. Sales Footprint
19.3.2.5. Strategy Overview
19.3.2.5.1. Marketing Strategy
19.3.2.5.2. Product Strategy
19.3.2.5.3. Channel Strategy
19.3.3. Biofrontera
19.3.3.1. Overview
19.3.3.2. Product Portfolio
19.3.3.3. Profitability by Market Segments (Product/Channel/Region)
19.3.3.4. Sales Footprint
19.3.3.5. Strategy Overview
19.3.3.5.1. Marketing Strategy
19.3.3.5.2. Product Strategy
19.3.3.5.3. Channel Strategy
19.3.4. Novartis AG
19.3.4.1. Overview
19.3.4.2. Product Portfolio
19.3.4.3. Profitability by Market Segments (Product/Channel/Region)
19.3.4.4. Sales Footprint
19.3.4.5. Strategy Overview
19.3.4.5.1. Marketing Strategy
19.3.4.5.2. Product Strategy
19.3.4.5.3. Channel Strategy
19.3.5. Allergan Plc
19.3.5.1. Overview
19.3.5.2. Product Portfolio
19.3.5.3. Profitability by Market Segments (Product/Channel/Region)
19.3.5.4. Sales Footprint
19.3.5.5. Strategy Overview
19.3.5.5.1. Marketing Strategy
19.3.5.5.2. Product Strategy
19.3.5.5.3. Channel Strategy
19.4. Competition Deep Dive (PDT Device Manufactures)
19.4.1. Valeant Pharmaceuticals International, Inc.
19.4.1.1. Overview
19.4.1.2. Product Portfolio
19.4.1.3. Profitability by Market Segments (Product/Channel/Region)
19.4.1.4. Sales Footprint
19.4.1.5. Strategy Overview
19.4.1.5.1. Marketing Strategy
19.4.1.5.2. Product Strategy
19.4.1.5.3. Channel Strategy
19.4.2. Quest Pharmatech, Inc.
19.4.2.1. Overview
19.4.2.2. Product Portfolio
19.4.2.3. Profitability by Market Segments (Product/Channel/Region)
19.4.2.4. Sales Footprint
19.4.2.5. Strategy Overview
19.4.2.5.1. Marketing Strategy
19.4.2.5.2. Product Strategy
19.4.2.5.3. Channel Strategy
19.4.3. Hologic, Inc. (Cynosure Inc.)
19.4.3.1. Overview
19.4.3.2. Product Portfolio
19.4.3.3. Profitability by Market Segments (Product/Channel/Region)
19.4.3.4. Sales Footprint
19.4.3.5. Strategy Overview
19.4.3.5.1. Marketing Strategy
19.4.3.5.2. Product Strategy
19.4.3.5.3. Channel Strategy
20. Assumptions and Acronyms Used
21. Research Methodology